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AN INVESTIGATION OF THE ACTION OF MANGANESE
ON THE UTERUS PERTINENT TO ITS USE
IN DYSMENORRHEA*
EDWARD R. SMITH
For many years the late Dr. E. W. Smith, and following him
Dr. D. P. Smith,47 used manganese dioxide in treating primary
dysmenorrhea. Dr. A. L. Pierson"9 has also had success with this
drug and has suggested a study of the subject. Long-standing
dysmenorrhea, frequently so severe as to make the patient bed-fast
for the first days of menstruation, has been completely relieved
by the use of manganese dioxide in doses of 5 to 15 gr. three times
daily, with treatment usually begun a few days before the expected
period. An investigation now in progress suggests that manganese
chloride, in small doses every two hours during the period, is even
more effective.
Action of manganese
In 1885, Martin29 mentions a paper of Ringer and Murrell42
published in 1883 advocating manganese salts in treating amenor-
rhea. He also quotes Broadbent's observation' that ". . . manganese
seemed to have a special influence in promoting the return of the
catamenia . . ." Martin, himself, reported28 success in treating
amenorrhea with manganese in 1883, and in 1885 he presented case
records illustrating similar success in treating menorrhagia and
metrorrhagia.29 Upshur50 testified, in 1887, to the value of man-
ganese in menstrual disorders, including membranous dysmenorrhea.
Two years later O'Donovan published "A Plea for the Use of
the Manganese Compounds in Certain Forms of Dysmenorrhea,"
presenting several case histories supporting his claim that manganese
dioxide would entirely relieve from pain the majority of women
suffering with primary dysmenorrhea.32 In this, and in two subse-
quent papers33' 3 he discusses dosage, and the indications for and
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results of manganese medication in dysmenorrhea. He observed no
deleterious effect of the drug, even after long-continued use.
No later reports of this nature have been found, except for such
non-committal notes as that in the U. S. Dispensatory:5' "The salt
(MnO2) seems to possess some stimulant action on the uterine
mucosa and is still used in the treatment of amenorrhea," and Bas-
tedo's comment' that "Manganese dioxide and potassium perman-
ganate have a reputation as emmenogogues."
von Oettingen's study35 of the pharmacology of manganese con-
tains an exhaustive review of the literature up to 1935, except that
the early use of manganese in menstrual disorders is omitted.
Manganese is a familiar catalyst in inorganic chemistry, is a con-
stant and important constituent of plants, and, in animals, small
concentrations increase antitoxin formation, liver autolysis, and cell
respiration.
Studies by Reiman and Minot" indicate that absorption of man-
ganese oxides and silicates from the normal digestive tract is very
slow and incomplete, depending largely on the acidity of the gastric
juice. The subsequent rise in the blood level never exceeds twice
the normal manganese content of the blood (which averaged 0.013
mg. % in 14 cases, varying from 0.005 to 0.023 mg. %.). Elimina-
tion of manganese from the blood is very rapid, and the toxicity of
ingested manganese ores is very low.
The distribution of manganese after ingestion is mainly to the
liver, but after injection, intraperitoneal or subcutaneous, there is a
marked increase in the manganese content of the brain. It is stored
mainly in the liver, and is excreted in the feces, probably by the
colon, though partly in the bile. Urinary excretion is minimal.
The toxic effects of manganese occurringafter inhalation of man-
ganese dust have often been described. A typical Parkinsonian
syndrome is observed and the pathological lesions are found mainly
in the putamen, caudate nuclei, and globus pallidus. The similarity
of the lesions to those of carbon monoxide poisoning is significant, in
view of Sato's observation that toxic doses of manganese act by
depressing tissue oxidation. Similar lesions have been produced in
animals by parenteral injection of manganese, but they are not seen
after oral ingestion until the liver has first been severely damaged
by the manganese.
Working with concentrations of MnCI2 of 20 to 40 mg. %,
Dodel'6 concluded that manganese exerted an unselective effect on
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the autonomic nervous system, but he was probably only observing
an unselective depressant effect of manganese in toxic doses on tissue
metabolism in general.
de Jongh24 investigated a possible abortifacient effect of potas-
sium permanganate and concluded that this effect was dependent on
the oxidizing power of the molecule, not on the manganese. Small
concentrations of MnCl2 and MnSO4 had no effect on the isolated
guinea-pig uterus.
Various studies bearing on the influence of manganese on physio-
logical processes have been reported, such as those of Sato,44 who
concluded that manganese was a catalyst of cell oxidative processes,
and of Waddel, Steenbock, and Hart51 on the effects of manganese-
deficient diets on the growth, reproduction, and ovulation of rats.
The abnormalities reported by these workers could not be substan-
tiated by Orent and McCollum.", 8 Skinner, Van Donk, and
Steenbock46 affirmed that manganese is essential to normal estruc,
McCollum et al.27 described testicular degeneration in rats main-
tained upon a manganese-deficient diet, and Daniels and Everson14
noted a "congenital debility" in the offspring of rats kept on a
similar diet.
The once popular use of manganese in the treatment of the
anemias has been discontinued, and its use in dermatology has been
condemned by the Council on Pharmacy and Chemistry of the
American Medical Association.8
Nevertheless, it has recently been shown (Cowgill9' 10) that man-
ganese is essential to the activity of thiamin, and Perla and Sand-
berg"8 believe that manganese acts with thiamin as an oxidative
wtalyst and that the toxic effects of excess thiamin are really due to
lack of manganese. The tissues of birds with beri-beri are low in
manganese (Hamamoto22), the ascorbic acid content of growing
seeds isincreasedby manganese (Rudra43), sugar oxidation is acceler-
ated bysmall amounts of manganese (Bodansky3), and Nott3" reports
the cure of four cases of parenchymatous goiter by the use of potas-
sium permanganate enemata.
Such is some of the evidence pointing to the r6le, or rOles, which
manganese may play.
Dysmenorrhea
"Primary," "idiopathic," and "non-surgical" are designations
for the type of dysmenorrhea in which manganese seems to be most
effective and with which this study deals. Curtis"3 mentions the
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workof Novak and Reynolds supportingtheir contention that, what-
ever the underlying cause of dysmenorrhea may be, the actual pain
results from a spasmodic contraction of the uterine muscle. The
action of theelin to excite rhythmic uterine contractions and of pro-
gestin to inhibit them is reviewed, and the now familiar theory of
theelin excess (or progestin lack) as causing dysmenorrhea is pro-
posed. Fluhmann"7 discusses objections to this theory and Sturgis
and Albright49 have shown, by endometrial biopsies, that when
estrogen therapy relieves dysmenorrhea it apparently does so by
suppressing ovulation.
Most writers, however, look for some form of endocrine imbal-
ance in primary dysmenorrhea. Crossen and Crossen"2 adjudge
hypothyroidism the most important single factor, and supporting
this contention is the work of Foster and Thornton,18 who treated
dysmenorrhea in 25 women with basal metabolic rates between
-1 and -32 (averaging -15) by giving thyroid extract. They
obtained complete relief in 17, good results in most of the rest.
Benedict and Finn2 and others7 20, 23 have shown that even in normal
women there is a significant drop in the basal metabolic rate during
menstruation. This suggests that border-line cases might actually
become hypothyroid during menstruation and suffer the dysmenor-
rhea of hypothyroidism.
Wendel,52 after Hertzler, describes a condition he calls "goiter-
ous dysmenorrhea" or "interstitial thyrotoxicosis," presumably pro-
ducing "mild, chronic hyperthyroidism," not demonstrable by
changes in the basal metabolic rate. The thyroids are found to be
large, red-brown, and rubbery and most of the patients live in the
mid-west goiter belt. It seems at least as likely that these patients
have dysmenorrhea because their thyroids are underfunctioning dur-
ing menstruation as it does that they have mild hyperthyroidism.
Potassium iodide was used with success in treating these cases.
Hypothesis
The following argument is presented as a basis for the present
thesis.
Whether or not spasm of the uterus occurs in dysmenorrhea is
of little importance, unless such spasm can be shown to be the cause
of the pain. Further, one must avoid the error of calling exagger-
ated contractions spasm. Even a maximal contraction in a normally
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functioning skeletal muscle is known not to cause pain unless it
actually traumatizes tissue. Conversely, pain is frequently encount-
ered in muscle, after severe exercise, where there is no evidence of
spasm. Pain is, moreover, frequently seen in muscle exercized in
the face of an inadequate blood supply. Intermittent claudication,
swimmers' cramps, and perhaps angina pectoris are familiar examples
of this. Boland4 has published a report of his success in relieving
the pain of coronary thrombosis and angina pectoris by administering
oxygen. He feels that this supports Lewis's contention26 that the
pain arising in ischemic muscle is the result of oxygen lack. Fluh-
mann17 quotes Markee, and also Moir, as attributing dysmenorrhea
to constriction of the vessels of the uterus with resulting ischemia
and oxygen lack. O'Donovan32 commented in his first paper that
many cases of dysmenorrhea associated with chlorosis and other
secondary anemias clear up when the anemia (and resulting anox-
emia) are relieved.
Granting, then, that anoxia in exercizing muscle can cause pain,
it is helpful, as a working hypothesis, to adopt Lewis's proposal
that the immediate cause of anoxial pain is chemical irritation pro-
duced by the presence of products of contraction, such as lactic
acid. Removal of these products could be hastened not only by
supplying oxygen, but also by increasing the enzyme-activated
processes of internal respiration. Indeed, failure of these processes,
as well as anoxia, might in some cases be responsible for pain in
muscle.
The three agents (excluding anodynes and surgical measures or
measures inhibiting ovulation) perhaps most successfully used to
treat dysmenorrhea, namely, manganese, thyroid extract, and potas-
sium iodide, all act, directly or indirectly, as catalysts of cellular
oxidative processes.
Admittedly, these catalysts of cell oxidative processes, man-
ganese and thyroxine (and iodine.through thyroxine), affect organs
other than the uterus. Their importance, for example, in maintain-
ing normal ovarian function is especially prominent and it may be
that their effect on dysmenorrhea is indirect.
The hypothesis which this study is intended to test is: that the
pain which is dysmenorrhea is caused bysome failure of the oxidative
processes of uterine muscle and that manganese (and thyroxine) if
they relieve that pain are acting as oxidative catalysts, improving the
internal respiration ofthe muscle tissue.
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Materials and methods
The experiments were planned to demonstrate whether or not
manganese has a direct, favorable action on the mechanics of uterine
contraction. Attempts were also made to show whether or not the
thyroid gland may exert similar effects. In addition, the effects of
a double deficiency, of manganese and iodine, on the action of the
uterus were investigated in view of the suggestion5' that these
elements may be complementary.
Diets and preparation:
Thirty-three young, normal, non-pregnant, albino rats were placed on
one of three diets; 15 were fed a control diet adequate in all essentials, 12
were deprived as far as possible of manganese, and the remaining 6 were
deprived of both manganese and iodine. All received only distilled water to
drink. The cages were so constructed that coprophagy was impossible.
Some animals were thyroidectomized.
The diet* was modeled after that on which Daniels and Everson' raised
5 consecutive generations of normal rats. By eliminating the added man-
ganese from this diet they were able to produce signs of manganese deficiency
("congenital debility"). The young of rats on such a diet contained 65
per cent less manganese in their tissues than those of normal rats. In our
cdiete the substitution of whole milk powder for liquid milk was made to pro-
vide a concentrated food and insure full caloric intake. Its adequacy was
suggested by Sherman's work45 and discussion with Professor Cowgfll.1" It
contains only 0.18 mg. of manganese per kg. By calculating the diet on a
caloric basis,40 the proportions of minerals advocated by Daniels and Everson
were retained. The deficient diets were made by eliminating from the stan-
dard diet in the first case manganese, in the second case manganese and
iodine. Diets were prepared fresh every week or two and were kept under
refrigeration. The rats received the food ad libidum and were weighed
every two weeks.
The thyroid glands were removed, under ether anesthesia, from rats
1-R, 2-R, 2-0, 4-R, 7-R, and 8-L. Recovery was prompt and complete,
with no signs of parathyroid tetany in any case. Though complete thyroidec-
tomy was not attempted, at least seven-eighths of the gland was removed
in every case.
* Diet of Daniels and Everson Modification using milk powder
Boiled milk (70 cal.).. 100 cc. Whole milk powder (70 cal.).. 14.0 gm.
Iron ............. 5.0 mg. FeCl ................... 14.2 mg.
Copper ............. 0.8 mg. CuS04 ...................2.0 mg.
Manganese ............. 1.5 mg. MnCl2....................3. 5mg.
2%o KI solution .......... 2 drops Lugol's solution................... 1/10 drop
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Rat uterus experiments:
Except in the first few experiments, in which Tyrode's solution was used,
the following technic was employed in investigating the activity of the uteri
and the effect of pitocin and manganese.
The rats were kflled and the entire uterus dissected free of mesentery
and ovaries. Equal and symmetrical portions of the two horns were then
isolated and adjusted for recording contractions.
The effect of MnCl2 in varying concentrations on these contractions and
on the contractions produced by various dilutions of pitocin was then studied.
In some instances, as . b oot O t Z ,,,z. ,a,, o N p , , tl ,
detailed below, other M "
Con~trols42 drugs were used in ex- Mu eticimt ---- -
periments intended to Thu4IodinckE ..............
throw light upon the
mechanism by which
manganese produced its ----- --
observed effect.
Thesamelotofpito- ..
cin,* assayed according
to the method of Kamm .f ..
and reported to contain.
10 oxytocic units and A.. 8
0.1 pressor unit per cc., FIG. 1. Average weight curves for the three
was used throughout diet groups.
the experiments. The
dilutions referred to in the records represent dilutions of this solution, not
fractions of a unit. Thus 1 cc. of "Pitocin 1:500" contains 1/50 of a unit.
Manganese was used as the chloride, MnCl2, certain convenient dilutions
having been made up with doubly distilled water at the beginning of the
study and used throughout. Solutions were used of such concentrations
that the introduction of a very few drops would bring about the desired con-
centration of manganese in the bath, without significantly altering the con-
centration of the salts in the Ringer-Locke solution.
Results
Figure 1 presents the average weight curves of the three diet
groups, excluding the weights of the thyroidectomized rats and of a
rat with a huge tumor. The rats on the manganese-deficient diet
gained as well as the controls, an observation in keeping with the
* This solution, containing the oxytocic principle of the posterior lobe of the
pituitary gland, had been very kindly supplied to the laboratory by Dr. Kamm
several years previously. It exhibited no significant loss of activity.
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reports of others,27 but the rats deprived of both manganese and
iodine exhibited a significant lag in growth. Rats 6-R and 10-R
developed tumors and rats 4-L and 5-R became malnourished, for
reasons not evident. The thyroids of all the rats were examined
grossly and in no instance appeared abnormal.
The experiments done on 16 of the rats in this series were so
conducted that the results may be compared, and it is from these
that the findings are drawn. The 16 rats are divided into groups of
4 each, one group having been thyroidectomized, one deprived of
manganese, one deprived of manganese and iodine, and one serving
as a control group receiving the complete diet. In every case, both
uterine horns were used and studied separately, though simultane-
ously, so that for practical purposes, 32 experiments are represented.
The recording periods in each experiment averaged about 4>2 hours.
Spontaneous activ'ty: The degree of spontaneous activity in each
uterus was determined by counting the contractions in a I0-minute
period. The figures so obtained are presented in Table 1. It is
apparent that various degrees of activity occurred in each of the 4
groups of rats studied. This is to be expected, since no attempt
was made to sacrifice the rats in comparable stages of estrus, and it
is known that the spontaneous rhythmic contractions of the uterus
vary markedly with the estrual cycle.25
Manganese and spontaneous activity: Dodel has shown that very
high concentrations of manganese (20 mg. % and above) depress
spontaneous activity, and it was easy to confirm this observation.
Low concentrations of manganese, such as have been produced in
the blood stream by the oral ingestion of manganese salts,4" were
found to have no significant effect on spontaneous activity. In fact,
even concentrations exceeding 20 times the highest reported blood
level were ineffectual. In 29 instances, each time with a different
specimen, MnCI2, in concentrations ranging from 0.02 to 0.8 mg. %,
was introduced to a fresh, spontaneously contracting uterus. In 24
of these cases it was clear that the manganese did not significantly
alter the tone, amplitude, or frequency of the contractions. Some
depressing effect, never marked, was observed in 5 cases, but a
stimulating effect was never observed (Fig. 2B). All 16 rats were
represented in this study. The results appear in Table 1.
Effect of pitocin: Pitocin was observed to increase three measurable
qualities of uterine activity: frequency of contractions, height of con-
tractions, and tone. In Table 1 the increases in frequency caused by
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various strengths of pitocin are expressed as the ratio of the number
of contractions in a given interval after the addition of pitocin to
the number in an equal interval before pitocin was added. Simi-
larly (Table 3), the increase in height of contractions is expressed as
the quotient obtained by dividing the average height of contractions
after the addition of pitocin by the average height before adding
pitocin. The increase in tone was measured directly in millimeters,
but is omitted as unimportant.
It is evident from Table 1 and, more clearly, from Table 2,
that the ability of pitocin to increase the frequency of uterine con-
TABLE 2
SUMMARY OF EFFECTS OF PITOCIN AND MANGANESE, EXPRESSED AS AVERAGES OF
FREQUENCY RATIOS
MnCl2 MnCl2 MnCl2 MnCl2 AMnCl2
Pit- 0.04 Pit- 0.04 Pit- 0.02 0.04 0.3
oci mg. %mg. % oci mg. % mg. 0 mg.
1 after I after 1 after after after
10,000 pitocin 5000 pitocin 500 pitocin pitocin pitocin
Control group 1.1 1.1 1.3 1.2 2.1 1.2 1.2 1.2
Manganese
deficient 1.0 1.1 1.2 1.2 1.7 1.2 1.2 1.3
Thyroid-
ectomized 2.2 1.1 2.7 1.3 4.0 1.2 1.2 1.4
Manganese
and iodine
deficient 1.4 1.0 2.6 1.2 3.3 1.2 1.2 1.3
tractions is more marked in the uteri of the thyroidectomized rats
and the rats deprived of manganese and iodine than in the uteri of
the control rats and thosedeprived only of manganese. Theincrease
in the height of contractions caused by pitocin was not significantly
different in the four groups (Table 3) nor was the increase in tone.
Effect of manganese after pitocin: The effect of manganese on the
contractions produced by pitocin was also measured as to increase in
frequency, height of contractions, and tone. The figures represent-
ing the amount of such increases were arrived at in a manner similar
to that used in evaluating the effect of pitocin. The increases in
frequency caused by each concentration of manganese found in
Tables 1 and 2 were measured by dividing the number of contrac-
tions in an interval after the addition of manganese with the num-
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TABLE 3
EFFECTS OF PITOCIN AND MANGANESE ON HEIGHT OF CONTRACTIONS
Pit-
ocin
Rat I
No. 10,000
4-L
4-0
5-L
5-R
1.3
1.5
1.0
1.3
Avg. 1.3
8-R 1.1
8-0 ....
9-L 1.6
9-0 1.1
Avg. 1.3
2-0 1.9
4-R 1.0
7-R 1.2
8-L 1.0
Avg. 1.3
1O-L 1.0
10-0 1.3
11-R 1.0
11-L ....
Avg. 1.1
MnC'2
Pt 0.04 Pi
mg. % ocin
after_ 1
pitocin 5000
1.0
1.0
....
1.0
1.0
1.0
....
1.0
1.0
1.0
1.1
....
1.0
1.0
1.0
1.3
1.1
1.0
....
1.1
1.1
1.2
1.4
1.0
1.2
1.1
1.0
....
1.2
1.1
3.0
1.1
1.0
1.7
1.4
1.4
2.1
1.3
1.6
MnCl2 MnCl2 MnCl2 MnCl2
0.04 Pit- 0.02 0.04 0.3
mg. %0 ocin mg. %o mg. % mg. %
after 1 after after after
pitocin 500 pitocin pitocin pitocin
1.0 1.0 .... .... 1.2
1.0 1.4 1.0 1.0 1.2
1.0 .... .... .... ....
1.0 1.3 1.0 1.0 1.0
1.0 1.2 1.0 1.0 1.1
1.0
1.0
....
1.0
1.0
1.1
....
1.0
1.0
1.0
1.1
1.0
1.0
1.0
1.0
1.5 1.1
2.9 1.0
1.7 ....
1.2 1.0
1.8 1.0
2.5 1.0
1.0 ..
1.2 1.0
1.0 ....
1.4 1.0
1.9 1.0
1.4 1.0
2.6 ....
1.3 ....
1.8 1.0
1.1 1.1
1.0 1.1
1.0 1.0
1.0 1.0
1.0 1.1
1.0 1.0
1.0 1.0
1.0 1.0
1.0 1.0
1.0 1.0
1.0 ....
1.0 1.1
1.0 1.0
1.0 1.1
1.0 1.1
ber in a similar interval in the presence of pitocin but before
manganese had been added. In the same manner, the height of
contractions after manganese was compared with that before man-
ganese had been added. Increases in tone were measured in milli-
meters but are not presented, since they did not differ materially
from one group to another but were greater, as would be expected,
with the higher concentrations of pitocin and manganese.
Since the increases in the frequency of contractions produced by
adding manganese are here expressed as ratios of the effect of pitocin
plus manganese to the effect of pitocin alone, the figure represent-
Controls
Manganese
deficient
1Thyroid-
ectomized
Manganese
and iodine
deficient
I
I
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ing this ratio would not be expected to change from one experiment
to another tunless the effect of manganese varied independently of
the effect of pitocin. Table 2 shows that there is no significant
difference in this figure in the four groups of rats. This is in strik-
ing contrast to the differences between the groups in their response
to pitocin alone. It leads to the conclusion that the effect of man-
ganese in such experiments varies directly with the effect of pitocin.
In general, it may be said that whenever pitocin has established
uterine contractions in any of the groups studied, non-toxic doses of
manganese increase either the frequency or the height of the contrac-
tions or both. The magnitude of this effect varies directly with the
response previously produced by the pitocin. Increasing the con-
centration of manganese increases the effect, up to a concentration
of 0.8 to 1 mg. % of MnC12, above which level toxic effects gradu-
ally become evident, as later described.
The ability of manganese to enhance the activity of the pitocin-
treated uterus can be demonstrated, under favorable conditions, for
initial concentrations of MnCI2 as low as 0.02 mg. % (Figs. 3 and
4). This represents a concentration of manganese of only 0.008
mg. %, less than half that which occurs in the blood after ingestion
of 0.77 gm. of manganese in a highly insoluble form, and even less
than the normal blood level of manganese. In the course of the
experiments, the effect of MnCl2 in concentrations of only 0.02
mg. % was demonstrated 15 times on the uteri of 9 different rats
with concentrations of pitocin varying from 1:10,000 to 1:500.
In concentrations of only 0.04 mg. % of MnCl2, manganese was
shown in 36 experiments, involving 24 uterine horns of 15 rats, to
increase the response of the uterus to pitocin in concentrations vary-
ing from 1:10,000 to 1:500 (Figs. 3 and 4).
As the concentrations of manganese were increased, more dramatic
results were obtained. Examples of these are illustrated in Figures
3 and 4.
Toxic effects of manganese are observed as the concentration of
MnCI2 is increased above 1 or 2 mg. %, their nature depending on
the concentration of pitocin present. With high concentrations
(1 :500 and above) the uterus becomes spastic, while with lower con-
centrations (1:5,000 and less) contractions are abolished and the
uterus is paralyzed in relative relaxation. Four or S mg. % of
MnCl2 usually cause a full toxic effect, i.e., cessation of activity in
either the spastic or relatively relaxed position (Figs. 3 and 4B).
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Observations with other drugs: The following additional observa-
tions bear upon the underlying mechanism of manganese action.
Their significance will become evident in the discussion to follow.
Magnesium. Tyrode's solution was shown to depress the spon-
taneous activity of the uterus (Fig. 5B). This effect must be
attributed to the presence of 10 mg. 7o of magnesium in the solution
(Fig. SC). In Tyrode's solution manganese did not exhibit its char-
acteristic action, that of increasing the response of the uterus to
pitocin (Figs. SA and SD). Equal concentrations of pitocin pro-
duced much greater response in the uterus in a medium of Tyrode's
solution than in Ringer-Locke solution. This is evident in the
comparison of Figs. 5A and 5D with 4B. These responses to pitocin
in Tyrode's solutionwere comparable tothose ofthe uteri, in Ringer-
Locke solution, subject to the action of non-toxic doses of man-
ganese and small toxic doses (2 or 3 mg. %), as is evident in the
comparison of Fig. SA with Fig. 3 and similar records.
Epinephrine, in concentrations as low as 1:10,000,000, relaxed
the ratuterus, even in the presence oftoxic doses of manganese acting
with concentrations of pitocin as high as 1:500 and above (Fig. 5A).
Atropine, 1 mg. %o, did not abolish or appreciably decrease the
effect of manganese with pitocin.
Barium chloride produced regular contractions in the uterus, in
concentrations of 1 and 2 mg. %, which are not affected by the addi-
tion of manganese (Fig. 2A).
Thiamin chloride,* in concentrations of from 0.0001 to 0.3
mg. %o had no apparent effect on the response of the uterus to
pitocin, either in the presence or absence of manganese.
Oxygen, 100 per cent, substituted for the air bubbling through
the bath, was observed to produce its classical effect, increasing the
frequency of the uterine contractions while decreasing their ampli-
tude. This effect was noted whether the uterus was contracting
spontaneously or after stimulation with pitocin.
Sodium chloride, in a concentration calculated to contain the
same number of chloride ions as 0.8 mg. % MnCl2 (0.74 mg. %
NaCI), had no effect on the pitocin-treated uterus.
Discussion
The evidence detailed above shows that concentrations of MnCI2
below 1 mg. % do not materially alter the spontaneous contractions
* Generously provided by Dr. Molitor of Merck and Company.
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of the uterus, but they do greatly enhance the response of the uterus
to pitocin. That this action of MnCl2 is due to the manganese and
does not depend on the chloride fraction is shown by the tests with
NaCl. Exactly how manganese acts is not yet clear, but much may
be inferred.
Manganese, itself, apparently does not stimulate the uterus, but
acts only in conjunction with some other particular substance which
does stimulate it. Pitocin is such a substance. Barium chloride
apparently is not, nor is the substance, nature unknown, which is
responsible for the spontaneous contractions of the uterus. Attempts
to produce regular contractions with histamine were unsuccessful,
but it appeared that manganese did not enhance the effect of this
drug.
The stimulating effect of manganese with pitocin is not through
either division of the autonomic nervous system. The fact that epi-
nephrine relaxes the rat uterus eliminates an adrenergic mechanism,
while atropine, in concentrations more than sufficient to paralyze
cholinergic activity, did not prevent the usual manganese effect.
Manganese, in this case, is apparently uninfluenced by thiamin,
since the addition of thiamin neither enhances the effect of man-
ganese nor decreases the toxic effects of high concentrations of
manganese.
In view of the fact that the role of manganese as a catalyst of
cellular oxidative processes is so well established, and because that
function is so fundamental that it may well underlie all the more
general effects of manganese which have been observed and reported,
it seems logical to interpret the manganese effect here observed in
terms ofthat known property. Arguing for this stand is the remark-
ably close parallel between the concentrations of MnCl2 effective
in thisexperiment and those found by Satoto affect tissue respiration.
Our experiments show that concentrations of MnCl2 below 1 mg. %
markedly increase the response of the uterus to pitocin, that larger
doses are ineffective in increasing this response further (except that
early toxic effects operating with high concentrations of pitocin imi-
tate increased stimulation), and that at concentrations at and above 5
mg. % the uterus is paralyzed. In Sato's experiments concentrations
of 1 mg. % MnCl2 stimulated tissue respiration, higher concentra-
tions decreased it and concentrations of 5 mg. % and above com-
pletely deranged tissue oxidations. Such a close parallel of results
cannot be ignored.
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The classical effects of increasing oxygen tension are seen to have
some qualitites in common with the effects of manganese, notably an
increased tonus and increased frequency of contractions when pitocin
is present, but they differ greatly in that oxygen affects spontaneous
contractions as much or more than it does contractions excited by
pitocin and in that it does not increase, but tends to decrease, the
height of contractions. It is not surprising that supplying extra
oxygen does not have an effect identical with supplying a factor pre-
sumably catalyzing some one phase of cell respiration.
That manganese and pitocin seem to be more effective in experi-
ments with the uteri of rats lacking in thyroid hormone and in those
kept on a diet deficient in manganese and iodine lends support to
the theory that their effect is due to an activity as oxidative catalysts,
because it might be expected that the addition of catalysts would be
more effective in the existence of a lack of such factors (and thy-
roxine is probably such a factor) than in the presence of essentially
normal oxidative processes.
An interesting question is raised by consideration of a report
recently published by Fraser"9 describing experiments which show
that magnesium increases the sensitivity of the rat uterus to both
the pressor and oxytocic hormones of the posterior pituitary. Con-
centrations as low as 0.1 mg. % were found to be effective, the
maximal sensitization occurring at 2 to 5 mg. % with the oxytocic
fraction. Concentrations above these values depressed the sensitivity
of the uterus. Magnesium appeared to depress rather than enhance
the reaction ofthe uterus to histamine and ergobasine tartrate. The
striking similarity of these effects of magnesium to those here
reported for manganese, plus the observed failure of manganese to
act in Tyrode's solution, where magnesium is already present to the
extent of 10 mg. %, suggest that the action of the two metals may
be very similar. Manganese may be, as magnesium is known to be,
an essential element in the chemistry of muscle contraction. The
close relationship between manganese and thiamin, now considered
essential for the removal of pyruvic acid and, as a secondary conse-
quence, of lactic acid, from the tissues, lends strong support to such
a belief.' 15, 53
How manganese and magnesium act to increase the response of
the uterus to pitocin can only be surmised, since the chemical nature
and mechanism of action of pitocin are still unknown. Under some
conditions, these metals are known to act as enzyme catalysts. For
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this reason, and because they do not increase spontaneous contrac-
tions or the contractions produced by histamine, barium chloride, or
ergotamine tartrate, it is suggested that here, too, they act as enzyme
catalysts and that pitocin is immediately concerned in the reaction,
possibly itself an enzyme or an essential catalyst for an enzyme
accelerating metabolism in uterine muscle. If this could be estab-
lished, it might serve to unite into one harmonious theory two obser-
vations of fact, namely, that manganese stimulates tissue oxidative
processes and that exactly similar concentrations of manganese
increase the response of the uterus to pitocin.
How manganese may act to relieve dysmenorrhea, assuming that
it does, is equally problematical. It is quite reasonable to suppose,
since manganese has here been shown to act (with pitocin) directly
on the uterine muscle and not through the autonomic nervous sys-
tem, that manganese (with pitocin) would have an action on the
human uterus comparable to that observed onthe rat uterus. Assum-
ing, then, the presence in the blood, at least during menstruation, of
some posterior pituitary hormone or similar substance, the oral inges-
tion of manganese in sufficient amount to elevate the blood man-
ganese level could enhance the action of this substance, facilitating
the contraction of the uterus. It has been suggested that such facili-
tation of contraction by manganese (with pitocin) is accomplished
by improving tissue respiration. This action would necessarily
involve the correction of that state of depressed oxidative processes
earlier proposed as theunderlyingcause ofthepain ofdysmenorrhea.
If the success Martin claimed for manganese in the treatment
of other menstrual disturbances29 could be confirmed, this same view
of the action of manganese might explain that success. Martin's
insight into the problem is reflected in his opinion, expressed over
half a century ago, that". . . its [manganese] action is prompt, and
direct in bringing the uterus and appendages into a normal state of
menstrual tonicity."
The role of the thyroid hormone in dysmenorrhea has not been
disclosed by this investigation. Whether it acts directly on the
uterine muscle as an oxidative catalyst or through the ovary in some
manner, or through the pituitary, possibly to increase the output of
some oxytocic hormone, can only be conjectured.
We may be sure that, even if manganese therapy is effective in
relieving dysmenorrhea, failure will attend the improper use of the
drug. Indeed, improper use may have been responsible for its fall-
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ing from favor. Knowledge that it is poorly absorbed, rapidly
removed from the blood stream, and most effective in concentrations
around 0.8 mg. % of MnCl2 should suggest to clinicians the use of
manganese chloride instead of the dioxide, in frequent small doses
instead of infrequent, large ones, the dose to be determined, at least
in the beginning, by the blood manganese levels attained. It might
even prove beneficial to supplement manganese medication with
small amounts of pitocin.
In view of its auxiliary oxytocic property, herein demonstrated,
it seems appropriate to suggest further the use of manganese with
pitocin in the induction of labor, with the understanding that great
caution should attend the first trials of this combination.
Summary
The hypothesis is proposed that dysmenorrhea, like many other
forms of visceral pain, is closely related to impaired tissue respira-
tion. When not caused by actual anoxia it may well be attributed
to failure of some part of the enzyme-activated oxidation-reduction
system of uterine muscle.
Experiments are described which show that MnCl2, in concentra-
tions of less than 1 mg. %, increases the response of the rat uterus
to pitocin, this effect varying directly with the original effect of pito-
cin on the uterus. Similar concentrations of MnCl2 have no effect
on the spontaneous contractions of the uterus or on those produced
by barium chloride. Concentrations of MnCI2 above 1 mg. % are
shown to depressuterine contractions, regardless of their origin.
The uteri of thyroidectomized rats and of rats deprived of both
manganese and iodine were more responsive to pitocin and subse-
quently to manganese than those of normal rats. The uteri of man-
ganese-deficient rats behaved essentially the same as those of the
controls.
The dose of manganese required to increase tissue oxidation
(Sato) agrees with that needed to increase the response of the uterus
to pitocin. A striking similarity to the action of magnesium is
observed. The suggestion is made that pitocin is a respiratory
enzyme or catalyst involved in the metabolism of uterine muscle and
is in turn catalyzed by manganese (or magnesium, etc.).
It is concluded that the alleged effectiveness of manganese in
relievingdysmenorrhea may well depend on an interaction with pito-
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cin or some similar hormone to improve the internal respiration of
uterine muscle. Certain suggestions are made relevant to the clini-
cal use of the drug.
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22nd Ed. J. B. Lippincott Co., Philadelphia, 1937.FIG. 2. A) Failure of MnCI2 to increase contractions caused by BaCl2.
B) Failure of MnCl2 to increase spontaneous contractions.
FIG. 3. Effect of increasing and toxic concentrations of MnCl., in the presence
of pitocin.FIG. 4. Effect of increasing concentrations of MnCl, with (A) pitocin
1:10,000 and (B) pitocin 1:5,000 and 1:500.
FIG. 5. A) Exaggerated effect of pitocin in the presence of magnesium;
subsequent lack of manganese effect; relaxing action of epinephrine. B) Depressing
effect of Tyrode's solution on spontaneous contractions. C) Similar effect produced
by 10 mg. %o MgCl2 added to Ringer-Locke solution. D) Exaggerated effect of
pitocin in Tyrode's solution; lack of manganese effect.